Nifty 50
- JSW Steel₹1,32733.30 (2.57%)
- SBI Life Insurance ₹1,761.80-31.10 (-1.73%)
- Hindalco Industries₹1,058.5024.50 (2.37%)
- Bajaj Finance₹1,077-18.00 (-1.64%)
- Tata Steel₹186.303.30 (1.80%)
- Adani Ports₹1,672.10-27.90 (-1.64%)
- HCL Technologies₹1,32219.50 (1.50%)
- Bajaj Finserv₹2,001.70-30.80 (-1.52%)
- Dr. Reddy's Labs₹1,19015.30 (1.30%)
- Bharat Electronics₹409-5.00 (-1.21%)
- Tata Consumer ₹1,062.5013.50 (1.29%)
- Tata Motors PV₹314.40-3.50 (-1.10%)
- Bajaj Auto₹11,800100.00 (0.85%)
- Shriram Finance₹1,119-11.00 (-0.97%)
- Infosys₹1,1309.00 (0.80%)
- Max Healthcare₹990.50-9.50 (-0.95%)
- Hindustan Unilever₹2,03015.00 (0.74%)
- SBI₹1,039.50-9.20 (-0.88%)
- Eicher Motors₹8,04737.00 (0.46%)
- Jio Financial ₹242-2.00 (-0.82%)
- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Margin Pledge Calculator
- Markets
Stocks
F&O
Mutual Funds
- More
Sector: Pharmaceuticals & Biotechnology
|Large Cap
Ipca Laboratories Share Price
IPCALAB
₹1,921
Ipca Laboratories Performance
Price Movement
₹1898.00
₹1938.00
1 Year Performance
₹1251.60
₹1945.10
Markets Today
Historical Performance
Summary
As of 25-08-2026 01:22, Ipca Laboratories Ltd. share price today is ₹0, with a change of ₹-1911.20 (-100.00%) from the previous close of ₹1911.2. The stock opened at ₹1920.6 and traded between ₹1898 and ₹1938, with a total traded volume of 277434 shares. The company has a market capitalization of ₹48487.9 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹1945.1 and ₹1251.6, respectively.
Ipca Laboratories Ltd. valuation metrics include a P/E ratio of 37, EPS of ₹46.94, and book value of ₹5.70. Profitability indicators show ROE of 14.15% along with a dividend yield of 0.3%. Ipca Laboratories Ltd. has reported revenue of ₹10125.58 Cr and net profit of ₹1309.8 Cr.
Ipca Laboratories Ltd. technical indicators include Day RSI at 64.48, Day MFI at 93.08, Day ADX at 24.42. Additional indicators include Commodity Channel Index (CCI) at 138.9 and Williams %R at -12.52. Momentum indicators show Day MACD at 38.17, Day MACD Signal Line at 21.75, DayATR at 68.86. Rate of Change indicators for Ipca Laboratories Ltd. include ROC125 at 28.13 and ROC21 at 7.9.
Exponential moving averages include EMA5 at ₹1882, EMA10 at ₹1844.7, EMA12 at ₹1834.9, EMA20 at ₹1810.1, EMA26 at ₹1796.7, EMA50 at ₹1750.1, EMA100 at ₹1675.7, EMA200 at ₹1589.8. Simple moving averages include SMA5 at ₹1896.3, SMA10 at ₹1821.3, SMA20 at ₹1785.8, SMA30 at ₹1800.3, SMA50 at ₹1745.7, SMA100 at ₹1645, SMA150 at ₹1593.8, SMA200 at ₹1550.4.
Support levels for Ipca Laboratories are placed at First Support ₹1892.87, Second Support ₹1874.53, Third Support ₹1859.97. Resistance levels are seen at First Resistance ₹1925.77, Second Resistance ₹1940.33, Third Resistance ₹1958.67. Ipca Laboratories Ltd. shareholding pattern shows promoter holding at 44.72%, FII holding at 10.72%, DII holding at 0%, public holding at 7.19%.
Ipca Laboratories Fundamentals
Ipca Laboratories Financials
Indicator | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 |
|---|---|---|---|---|---|
| Total Revenue | 2,119.24 | 1,814.35 | 1,845.18 | 1,930.32 | 1,746.90 |
| Operating Expense | 1,541.60 | 1,383.17 | 1,367.70 | 1,465.61 | 1,339.98 |
| Operating Profit | 577.64 | 431.18 | 477.48 | 464.71 | 406.92 |
| Depreciation | 74.61 | 70.31 | 68.57 | 66.86 | 63.13 |
| Interest | 5.04 | 10.48 | 9.51 | 11.46 | 12.06 |
| Tax | 142.12 | 87.56 | 113.77 | 103.57 | 94.71 |
| Net Profit | 373.29 | 262.29 | 303.45 | 304.74 | 262.04 |
Ipca Laboratories Technicals
Ipca Laboratories Ltd. EMA & SMA
₹1921.00
↗ Bullish Moving Average
16
↘ Bearish Moving Average
0
Ipca Laboratories Support and Resistance
Resistance
Support
Technical Indicators
Ipca Laboratories Shareholding Pattern
| Held By | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|
| Promoter | 44.7 | 44.7 | 44.7 | 44.7 | 44.7 | 44.7 |
| FII | 10.8 | 10.7 | 10.4 | 10.6 | 10.6 | 10.7 |
| DII | 36 | 36.2 | 36.8 | 37.3 | 37.5 | 37.4 |
| Public | 8.4 | 8.4 | 8.1 | 7.3 | 7.2 | 7.2 |
Ipca Laboratories Delivery And Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 1.12 L | 2.21 L | 50.92% |
| Week | 5.07 L | 19.38 L | 26.16% |
| 1 Month | 2.14 L | 6.81 L | 31.48% |
| 6 Month | 1.96 L | 3.89 L | 50.47% |
Ipca Laboratories SWOT Analysis
Growth Factor Screener: Rising returns on equity (ROE), Momentum, and Earnings Yield
Benjamin Graham Value Screen
Strong Performer, Getting Expensive (DVM)
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Companies with 10% increase in share price over three months, with rising net profit growth
Stocks with High Durability and EPS growth (subscription)
Stock passes majority of CANSLIM Investment criteria
Strong Momentum: Price above short, medium and long term moving averages
Relative Outperformance versus Industry over 1 Month
Relative Outperformance versus Industry over 1 Year
Companies with high TTM EPS Growth
Growth Stars: Strongest Annual EPS Performers
Annual Profit Growth higher than Sector Profit Growth
PEG lower than Industry PEG
High Momentum Scores (Technical Scores greater than 50)
Good quarterly growth in the recent results
Relative Outperformance versus Industry over 1 Week
Relative Outperformance versus Industry over 1 Month
Overbought by Money Flow Index (MFI)
Effectively using its capital to generate profit - RoCE improving in last 2 years
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Net Profit with increasing Profit Margin (QoQ)
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Annual Net Profits improving for last 2 years
Companies with Zero Promoter Pledge
Recent Results : Growth in Operating Profit with increase in operating margins (YoY)
Near 52 Week High
Negative to Positive growth in Sales and Profit with Strong Price momentum
RSI indicating price strength
Top Gainers
Stocks near 52 Week High with Significant Volumes
Stocks Outperforming their Industry Price Change in the Quarter
Ipca Laboratories Corporate Action
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 07 Aug, 2026 | 6 | FINAL | 07 Aug, 2026 | Equity Share |
| 05 Aug, 2025 | 2 | FINAL | 05 Aug, 2025 | Equity Share |
| 25 Nov, 2024 | 2 | INTERIM | 25 Nov, 2024 | Equity Share |
| 06 Aug, 2024 | 2 | FINAL | Equity Share | |
| 22 Nov, 2023 | 2 | INTERIM | 22 Nov, 2023 | Equity Share |
| 22 Nov, 2022 | 4 | INTERIM | 23 Nov, 2022 | Equity Share |
| 22 Nov, 2021 | 8 | INTERIM | 23 Nov, 2021 | Equity Share |
| 13 Nov, 2020 | 8 | INTERIM | 17 Nov, 2020 | Equity Share |
| 18 Feb, 2020 | 5 | INTERIM | 20 Feb, 2020 | Equity Share |
| 06 Aug, 2019 | 3 | FINAL | Equity Share |
Ipca Laboratories Stock Comparison
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹1,766 | ₹883.60 | ₹1,436.80 | ₹1,862 | ₹2,374.50 | ₹212.43 |
| % Change | 2.39% | 1.39% | -1.41% | -0.05% | -0.40% | -0.58% |
| Revenue TTM (₹ Cr) | ₹1,935.80 | ₹2,002.34 | ₹2,250.36 | ₹9,683.45 | ₹14,737.88 | ₹9,205.28 |
| Net Profit TTM (₹ Cr) | ₹288.22 | ₹575.94 | ₹361.74 | ₹1,011.39 | ₹2,042.67 | ₹-313.62 |
| PE TTM | 99.10 | 85.20 | 85.50 | 34.90 | 48.20 | -90.70 |
| 1 Year Return | 255.61 | 5.9 | 57.4 | 24.77 | -8.55 | 10.85 |
| ROCE | 24.32 | 27.56 | 18.38 | 25.65 | 14.32 | 2.29 |
Similar Stocks
ACUTAAS
Acutaas Chemicals Ltd.
₹ 3171.00
+0.06%
GLAND
Gland Pharma Ltd.
₹ 2811.90
-0.26%
LAURUSLABS
Laurus Labs Ltd.
₹ 1801.00
-0.06%
ALKEM
Alkem Laboratories Ltd.
₹ 5350.00
-0.93%
BIOCON
Biocon Ltd.
₹ 409.40
-1.48%
DIVISLAB
Divi's Laboratories Ltd.
₹ 8496.00
-1.17%
GRANULES
Granules India Ltd.
₹ 857.00
-0.13%
AJANTPHARM
Ajanta Pharma Ltd.
₹ 3581.00
-1.62%
ZYDUSLIFE
Zydus Lifesciences Ltd.
₹ 1103.80
-1.45%
GLENMARK
Glenmark Pharmaceuticals Ltd.
₹ 2390.70
+3.14%
WOCKPHARMA
Wockhardt Ltd.
₹ 1902.00
+0.83%
AUROPHARMA
Aurobindo Pharma Ltd.
₹ 1608.00
-0.82%
SUNPHARMA
Sun Pharmaceutical Industries Ltd.
₹ 1910.00
+0.40%
NEULANDLAB
Neuland Laboratories Ltd.
₹ 22901.00
-1.72%
GLAXO
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2930.00
+0.96%
PFIZER
Pfizer Ltd.
₹ 4886.00
-1.85%
ABBOTINDIA
Abbott India Ltd.
₹ 26450.00
+0.84%
TORNTPHARM
Torrent Pharmaceuticals Ltd.
₹ 4886.50
-0.20%
LUPIN
Lupin Ltd.
₹ 2188.00
-0.63%
DRREDDY
Dr. Reddy's Laboratories Ltd.
₹ 1190.00
+1.30%
CIPLA
Cipla Ltd.
₹ 1437.90
+0.40%
FAQ's on IPCALAB
What is the current share price of Ipca Laboratories Ltd.?
What is the Market Capitalization of Ipca Laboratories Ltd.?
What are the PE and PB ratios for Ipca Laboratories Ltd.?
What is the 52-Week High and Low for Ipca Laboratories Ltd.?
What is the current dividend yield for Ipca Laboratories Ltd.?
Who are the major shareholders of Ipca Laboratories Ltd.?
- Promoter
- Mutual Funds
- FII
- Public
- Other Institutions
(Note: Shareholding patterns can change; this represents major holders based on recent filings).
Who are the peers of Ipca Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?
What is the latest dividend information for Ipca Laboratories Ltd.?
By signing up I certify terms, conditions & privacy policy